Titan Pharmaceuticals, Inc. Operating Lease, Liability, Current
Titan Pharmaceuticals, Inc. had Operating Lease, Liability, Current of $33.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-03-20
- 2024-03-31: Operating Lease, Liability, Current $33.00K.
- 2023-12-31: Operating Lease, Liability, Current $65.00K.
- 2023-09-30: Operating Lease, Liability, Current $97.00K.
- 2023-06-30: Operating Lease, Liability, Current $128.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-03-31 | $33.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $65.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $97.00K 10-K · filed 2024-04-01 |
| 2023-06-30 | $128.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $125.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $122.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $120.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $117.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $114.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $112.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $109.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $108.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $76.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $150.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $222.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $292.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $282.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $272.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $262.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $253.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $243.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |